Supply of Investigational Drug. The Sponsor shall ensure the distribution of shipments of the Investigational Drug and placebo to the Institution’s pharmacy, where it shall be accepted and inspected by the delegated pharmacist (using the same procedure as for other shipments – i.e. check that no damage is present, in case of special transportation requirements, check that these requirements have been complied with, and confirm acceptance of the shipment). Subsequently, based on a request form, the Investigator shall collect the Investigational Drug and shall assume full responsibility for it. The Sponsor shall be obliged to provide a notification at least 3 working days prior to the delivery when the shipment will be delivered to the pharmacy, either by email to the address or by telephone. The Institution shall notify Sponsor of unused drugs in need of disposal or collection and shall cooperate with Sponsor in such disposal or collection. Sponsor shall arrange for the disposal or collection of unused drugs at Sponsor’s cost. The IP and placebo will be delivered to: Odd.HVLP, Ke Xxxxxxx 0, Xxxxx 0, responsible pharmacist 3.2 Dodávání hodnoceného léčiva. Zadavatel zajistí distribuci zásilky hodnoceného léčiva a placeba do lékárny zdravotnického zařízení, kde je odpovědný farmaceut převezme a zkontroluje (jako jiné zásilky - tzn., není-li poškozena, v případě zvláštních požadavků na transport, byly-li tyto požadavky dodrženy, příjem zásilky potvrdí), následně si na žádanku zkoušející hodnocené léčivo vyzvedne a je za ně plně zodpovědný. Zadavatel je povinen oznámit do 3 pracovních dnů před dodáním, kdy bude zásilka do lékárny předána buďto emailem na nebo telefonicky. Zdravotnické zařízení bude Zadavatele informovat o nevyužitých lécích, které bude třeba zlikvidovat nebo shromáždit, a bude se Zadavatelem při této likvidaci či sběru spolupracovat. Likvidaci či sběr nevyužitých léků si zadavatel zajistí na vlastní náklady. Zadavatel se zavazuje zajistit hodnocené léčivo a placebo v množství a časových intervalech potřebných pro řádné provedení studie. Hodnocené léčivo a placebo bude dodáno na adresu: Odd.HVLP, Ke Xxxxxxx 0, Xxxxx 0, xxxxxxxxx farmaceut . The Sponsor undertakes to provide the Investigational Drug and placebo in the amount and time intervals needed for the proper conduct of the Study. The Sponsor declares that all the conditions stipulated in the relevant legislation have been met for manufacture (import) of delivered investigational products and their distribution to the Inst...

Supply of Investigational Drug. The Sponsor and/or its Affiliate shall supply the Institution with quantities of the Investigational Drug adequate for the Institution to conduct the Study in accordance with the Protocol. The Investigational Drug shall remain the sole property of the Sponsor and/or its Affiliate. The Investigational Drug shall be delivered to the hospital pharmacy, always in duly packaged containers designed for the Investigational Drug and labeled in accordance with the provisions of Section 19(1)(e) of Decree No 226/2008 Coll. on Good Clinical Practice and detailed conditions of clinical trials on medicinal products. The Sponsor shall ensure the distribution of shipments of the Investigational Drug and placebo to the Institution’s pharmacy, where it shall be accepted and inspected by the delegated pharmacist (using the same procedure as for other shipments – i.e. check that no damage is present, in case of special transportation requirements, check that these requirements have been complied with) and acceptance of the shipment shall be confirmed. Subsequently, based on a request form, the Principal Investigator shall collect the Investigational Drug and shall assume full responsibility for it.

Related to Supply of Investigational Drug

Facilitation of Investigation In case of any allegation of violation of any provisions of this Pact or payment of commission, the BUYER or its agencies shall be entitled to examine all the documents including the Books of Accounts of the BIDDER and the BIDDER shall provide necessary information and documents in English and shall extend all possible help for the purpose of such examination.
Search, Enquiry, Investigation, Examination And Verification a. The Property is sold on an “as is where is basis” subject to all the necessary inspection, search (including but not limited to the status of title), enquiry (including but not limited to the terms of consent to transfer and/or assignment and outstanding charges), investigation, examination and verification of which the Purchaser is already advised to conduct prior to the auction and which the Purchaser warrants to the Assignee has been conducted by the Purchaser’s independent legal advisors at the time of execution of the Memorandum. b. The intending bidder or the Purchaser is responsible at own costs and expenses to make and shall be deemed to have carried out own search, enquiry, investigation, examination and verification on all liabilities and encumbrances affecting the Property, the title particulars as well as the accuracy and correctness of the particulars and information provided. c. The Purchaser shall be deemed to purchase the Property in all respects subject thereto and shall also be deemed to have full knowledge of the state and condition of the Property regardless of whether or not the said search, enquiry, investigation, examination and verification have been conducted. d. The Purchaser shall be deemed to have read, understood and accepted these Conditions of Sale prior to the auction and to have knowledge of all matters which would have been disclosed thereby and the Purchaser expressly warrants to the Assignee that the Purchaser has sought independent legal advice on all matters pertaining to this sale and has been advised by his/her/its independent legal advisor of the effect of all the Conditions of Sale. e. Neither the Assignee nor the Auctioneer shall be required or bound to inform the Purchaser of any such matters whether known to them or not and the Purchaser shall raise no enquiry, requisition or objection thereon or thereto.
Investigation and Prevention DST shall reasonably assist Fund in investigating of any such unauthorized access and shall use commercially reasonable efforts to: (A) cooperate with Fund in its efforts to comply with statutory notice or other legal obligations applicable to Fund or its clients arising out of unauthorized access and to seek injunctive or other equitable relief; (B) cooperate with Fund in litigation and investigations against third parties reasonably necessary to protect its proprietary rights; and (C) take reasonable actions necessary to mitigate loss from any such authorized access.
Complaints Investigation The employee who complains of harassment under the provisions of the Human Rights Code must first comply with the Employer’s harassment policy procedures before filing a grievance or human rights complaint.
Effect of Investigation The representations, warranties and covenants of the Indemnifying Party, and the Indemnified Party’s right to indemnification with respect thereto, shall not be affected or deemed waived by reason of any investigation made by or on behalf of the Indemnified Party (including by any of its Representatives) or by reason of the fact that the Indemnified Party or any of its Representatives knew or should have known that any such representation or warranty is, was or might be inaccurate or by reason of the Indemnified Party’s waiver of any condition set forth in Section 7.02 or Section 7.03, as the case may be.
Investigational Services This plan covers certain experimental or investigational services as described in this section. This plan covers clinical trials as required under R.I. General Law § 27-20-60. An approved clinical trial is a phase I, phase II, phase III, or phase IV clinical trial that is being performed to prevent, detect or treat cancer or a life-threatening disease or condition. In order to qualify, the clinical trial must be: • federally funded; • conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); or • a drug trial that is exempt from having such an investigational new drug application. To qualify to participate in a clinical trial: • you must be determined to be eligible, according to the trial protocol; • a network provider must have concluded that your participation would be appropriate; and • medical and scientific information must have been provided establishing that your participation in the clinical trial would be appropriate. If a network provider is participating in a clinical trial, and the trial is being conducted in the state in which you reside, you may be required to participate in the trial through the network provider. Coverage under this plan includes routine patient costs for covered healthcare services furnished in connection with participation in a clinical trial. The amount you pay is based on the type of service you receive. Coverage for clinical trials does not include: • the investigational item, device, or service itself; • items or services provided solely to satisfy data collection and that are not used in the direct clinical management; or • a service that is clearly inconsistent with widely accepted standards of care.
Grievance Investigation The Employer agrees to supply to the Union the names of all applicants for a vacancy, or new position in the course of a grievance investigation.
Grievance Investigations Where an employee has asked or is obliged to be represented by the Institute in relation to the presentation of a grievance and an employee acting on behalf of the Institute wishes to discuss the grievance with that employee, the employee and the representative of the employee will, where operational requirements permit, be given reasonable leave with pay for this purpose when the discussion takes place in the headquarters area of such employee and leave without pay when it takes place outside the headquarters area of such employee.
Compliance Investigations Upon City’s request, Contractor agrees to provide to City, within sixty calendar days, a truthful and complete list of the names of all subcontractors, vendors, and suppliers that Contractor has used in the past five years on any of its contracts that were undertaken within San Diego County, including the total dollar amount paid by Contractor for each subcontract or supply contract. Contractor further agrees to fully cooperate in any investigation conducted by City pursuant to City's Nondiscrimination in Contracting Ordinance. Contractor understands and agrees that violation of this clause shall be considered a material breach of the Contract and may result in Contract termination, debarment, and other sanctions.
Regulatory Investigations TCI and TLIC agree to cooperate fully in any insurance or judicial regulatory investigation or proceeding arising in connection with Contracts distributed under this Agreement. TCI and TLIC further agree to cooperate fully in any securities regulatory inspection, inquiry, investigation or proceeding or any judicial proceeding with respect to TLIC, TCI, their affiliates and their representatives to the extent that such inspection, inquiry, investigation or proceeding or judicial proceeding is in connection with Contracts distributed under this Agreement. Without limiting the foregoing: (a) TCI will be notified promptly of any customer complaint or notice of any regulatory inspection, inquiry investigation or proceeding or judicial proceeding received by TLIC with respect to TCI or any representative or which may affect TLIC’s issuance of any Contracts marketed under this Agreement; and (b) TCI will promptly notify TLIC of any customer complaint or notice of any regulatory inspection, inquiry, investigation or judicial proceeding received by TCI or any representative with respect to TLIC or its affiliates in connection with any Contracts distributed under this Agreement. In the case of a customer complaint, TCI and TLIC will cooperate in investigating such complaint and shall arrive at a mutually satisfactory response.

Supply of Investigational Drug Sample Clauses

Filter & Search

Related Clauses

Parent Clauses

Sub-Clauses

Related to Supply of Investigational Drug